Psychosocial adjustment and outcomes of glycaemic control with basal insulin therapy in patients with type 2 diabetes mellitus (T2DM)

被引：0
|
作者：
Tanenberg, R. J.
Zhang, Q.
Zisman, A.
机构：
[1] Sanofi Aventis US, Bridgewater, MA USA
[2] Endocrine Ctr Aventura, Miami, FL USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1054
引用
收藏
页码：S435 / S436
页数：2
相关论文
共 50 条
  • [21] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    [J]. DIABETOLOGIA, 2014, 57 : S440 - S440
  • [22] Factors Associated with Basal Insulin Persistence after Initiation among People with Type 2 Diabetes Mellitus (T2DM)
    Desai, Urvi
    Kabul, Samaneh
    Ivanova, Jasmina I.
    Kirson, Noam Y.
    Cummings, Alice Kate
    Ristovska, Ljubica
    Birnbaum, Howard G.
    Hadjiyianni, Irene
    Duan, Ran
    Cao, Dachuang
    Perez-Nieves, Magaly
    [J]. DIABETES, 2015, 64 : A223 - A223
  • [23] Efficacy of metformin alone or in combination with insulin in pediatric patients with type 2 diabetes mellitus (T2DM)
    Weinzimer, SA
    McKnight, WJ
    Murphy, K
    Jawad, AF
    Celona-Jacobs, N
    Haque, A
    Katz, LEL
    [J]. DIABETES, 2001, 50 : A68 - A68
  • [24] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
    Ayyagari, Rajeev
    Wei, Wenhui
    Cheng, David
    Pan, Chunshen
    Wu, Eric Q.
    [J]. DIABETES, 2013, 62 : A327 - A327
  • [25] TYPE 2 DIABETES MELLITUS (T2DM) IN PATIENTS WITH HIP FRACTURE (HF): PREVALENCE, COMORBIDITIES, AND OUTCOMES
    Chavalertsakul, Nuttaya
    Srikusalanukul, Wichat
    Fisher, Alexander
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 : 11 - 11
  • [26] LITERATURE REVIEW OF ECONOMIC AND CLINICAL OUTCOMES ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Mathur, I
    Trenery, A.
    Simon, A.
    Gala, S.
    Ermakova, A.
    Weiss, M.
    Taylor, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S149 - S149
  • [27] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [29] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [30] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
12345